# CAN SLIM Progress Board

Last updated: 2026-09-15

The theory-fidelity path through #54 is now closed. #54 is **COMPLETE / FROZEN WITH EXPLICIT PRODUCTION DEBT**. The project will not extend the research chain merely to reproduce proprietary IBD infrastructure. The next phase is an end-to-end CAN SLIM v1 integration audit followed by a production-baseline freeze.

## Repository boundary for #33

**Canonical #33 implementation and P8 morphology validation live in `azharmz/ussy-oneil-patterns`.** Frozen production contract: `oneil-pattern-output-v2` with only `FLAT_BASE`, `DOUBLE_BOTTOM`, `CUP_WITHOUT_HANDLE`, and `CUP_WITH_HANDLE`. P6 advanced patterns remain excluded and frozen.

## Theory Fidelity / v2 path

| # | Workstream | Status |
|---:|---|---|
| 25 | Theory Fidelity Audit | **COMPLETE** |
| 26 | Proper-base definitions | **COMPLETE** |
| 27 | Pivot / buy-point definition | **COMPLETE** |
| 28 | Breakout + volume confirmation | **COMPLETE** |
| 29 | RS / leadership fidelity | **COMPLETE** |
| 30 | C/A/S/I/M role fidelity | **COMPLETE** |
| 31 | Sell / risk-management fidelity | **COMPLETE** |
| 32 | Theory-faithful candidate specification | **COMPLETE / FROZEN v1** |
| 33 | O'Neil Pattern Recognition Engine | **CORE COMPLETE / FROZEN — P8 CONDITIONAL PASS** |
| 34 | Theory-faithful candidate generator | **COMPLETE / FROZEN v1** |
| 35 | New-candidate validation | **COMPLETE / FROZEN — CONDITIONAL PASS** |
| 36 | Execution / entry research | **BASELINE FROZEN / DIAGNOSTIC COMPLETE / PRIMARY PERFORMANCE VALIDATION BLOCKED_ON_ELIGIBLE_POPULATION** |
| 37 | Sell / risk execution semantics | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 38 | Technical deterioration evidence | **EVIDENCE LAYER COMPLETE / FROZEN v1** |
| 39 | Weekly aggregation / 10-week evidence | **WEEKLY AGGREGATION + 10W EVIDENCE COMPLETE / FROZEN v1** |
| 40 | Technical deterioration action semantics | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 41 | Position lifecycle / exit arbiter | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 42 | Round-trip sell action semantics | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 43 | Position lifecycle / exit arbiter v2 | **IMPLEMENTATION COMPLETE / FROZEN v2** |
| 44 | Climax / exhaustion evidence | **EVIDENCE LAYER COMPLETE / FROZEN v1** |
| 45 | Market exposure action semantics | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 46 | Market state evidence / classification | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 47 | Market input data contract | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 48 | Major index source audit | **SOURCE AUDIT COMPLETE — YAHOO/YFINANCE APPROVED FOR INITIAL PRODUCTION INPUT v1** |
| 49 | Production market index publisher | **PRODUCTION WIRING COMPLETE / LIVE v1** |
| 50 | Production market-state consumer | **PRODUCTION CONSUMER COMPLETE / LIVE v1** |
| 51 | Market leadership / weakening evidence | **EVIDENCE CONTRACT COMPLETE / PRODUCTION BOOLEAN SOURCE DEFERRED** |
| 52 | PIT broad-market leadership source audit | **SOURCE AUDIT COMPLETE / NO PRODUCTION BOOLEAN SOURCE APPROVED** |
| 53 | Prospective broad-market membership publisher | **PRODUCTION MEMBERSHIP ARCHIVE LIVE / LEADERSHIP BOOLEAN STILL DEFERRED** |
| 54 | PIT leader-cohort / institutional-demand evidence study | **COMPLETE / FROZEN WITH EXPLICIT PRODUCTION DEBT** |

## Current canonical architecture

```text
STOCK
#33 Pattern → #34 Candidate → #35 Validation → #36 Entry
→ OPEN POSITION
→ #37 Capital Protection / #40 Technical Deterioration / #42 Round-Trip
→ #43 Stock Lifecycle Arbiter → CLOSED POSITION

#44 Climax/Exhaustion = evidence sidecar only

GENERAL MARKET / CAN SLIM M
#49 production major-index data
→ #50 production consumer → frozen #46 Market State Classification
↑
#51 Leadership / Weakening Evidence contract
↑
#54 minimum evidence study CLOSED/FROZEN
  ├─ RS line vs canonical SP500: reproducible evidence complete
  ├─ stock-level institutional sponsorship: canonical SEC 13F source available
  ├─ full-market OHLCV / project IBD-RS replication: deferred, non-blocking
  └─ market-level leader aggregation boolean: NOT_EVALUABLE without new authorized evidence
→ #45 Portfolio Exposure Action
```

## Key frozen validation state

#34 final verification `34758050282` → **SUCCESS, 9 tests**. #35 canonical historical run `34763920536` produced 265,642 observations with zero V35-A/B/C findings and a frozen 60-case corpus. Independent source-evidence audit `34765922653` → **SUCCESS**, C/A/L/M 60/60 MATCH and PIT violations = 0. #35 remains `CONDITIONAL PASS` solely with upstream #33 morphology debt preserved.

#36 canonical T+1-open execution remains frozen; primary performance validation remains `BLOCKED_ON_ELIGIBLE_POPULATION` because canonical #35 has 0 `CANSLIM_ELIGIBLE` observations.

#37 capital protection, #40 technical deterioration and #42 round-trip are the three frozen executable stock-level exit channels. #43 v2 arbitrates them by earliest causal executable exit. Canonical validations remain green: #36 `34785545504`; #37 `34787905360`; #38 `34788119495`; #39 `34788414986`; #40 `34789559782`; #41 `34790106465`; #42 `34793348883`; #43 `34796938374`.

#44 contract `44-climax-exhaustion-evidence-v1` remains evidence-only. Canonical run `34797449482` → **SUCCESS, 10 passed**.

#45 contract `45-market-exposure-action-v1` remains frozen. Canonical run `34802432732` / job `103847631050` → **SUCCESS, 12 passed**.

#46 contract `46-market-state-classification-v1` remains frozen. Canonical run `34803676270` / job `103851194650` → **SUCCESS, 13 passed**.

#47 contract `47-market-input-data-contract-v1` freezes `NASDAQ_COMPOSITE`, `SP500`, and `DJIA`; SPY/QQQ/DIA are not substitutes. Run `34806193999` / job `103858438691` → **SUCCESS**.

## #48–#50 — Major-index production path

#48 approved Yahoo/yfinance for initial production input v1 for `^IXIC`, `^GSPC`, and `^DJI` after reproducible source audit. #49 publishes immutable major-index run objects and advances `market/indexes/official.json` only after complete publication; first live run `34808006835` succeeded. #50 verifies the pointer, manifest/object SHA-256 lineage and frozen #47 identity contract, then imports frozen #46. First live run `34809438828` produced `FOLLOW_THROUGH_CONFIRMED` as of 2026-09-11.

Because #51 market-level leadership/weakening booleans have no separately authorized deterministic source, #50 must preserve them as unavailable rather than fabricate promotion to `UPTREND_HEALTHY` or `UPTREND_WEAKENING`.

## #51–#54 — Leadership evidence closure

#51 freezes acceptable leadership/weakening evidence and keeps missing channels tri-state. #52 found no existing source stack that directly satisfies every production gate. #53 remains a live prospective PIT broad-market membership archive; membership is not itself a leader selector.

#54 has now reached its terminal evidence boundary. The earlier Cycle 1 broad-market percentile selector and provider audits are retained as frozen research history, but the ~7,500-security OHLCV reconstruction is **DEFERRED / NON-BLOCKING** for CAN SLIM v1. The project will not approximate proprietary IBD RS Rating merely to force this path.

Contract `54-rs-line-evidence-v1` provides reproducible PIT stock-versus-canonical-`SP500` evidence: RS-line value, prior-session direction, input-window-high/new-high state, provenance, and fail-closed `NOT_EVALUABLE` handling. Canonical CI run `34850590642` / job `103997238890` → **SUCCESS, 12 passed**.

Stock-level CAN SLIM `I` is also no longer a missing source. The canonical SEC 13F path in `azharmz/ussy-fundamentals` provides PIT-audited institutional sponsorship evidence and a live canonical R2 snapshot. Current-state run `34603142916` succeeded; canonical sponsorship publication run `34663714292` succeeded. SEC 13F remains delayed stock-level ownership/sponsorship evidence and is not treated as real-time institutional flow or a #51 market-state boolean.

Authoritative O'Neil market-direction material supports observing new leaders moving to new highs, strong price/volume behavior, and institutional accumulation/selling as market-leading-stock evidence. What it does not provide is a universal reproducible aggregation threshold for converting a project-defined cohort into the frozen #51 booleans. The project therefore will not invent `N leaders`, `X% of leaders`, or a new RS/volume threshold simply to make the boolean evaluable.

Terminal #54 decision: **COMPLETE / FROZEN WITH EXPLICIT PRODUCTION DEBT**. Market-level `leadership_confirming` / `weakening_confirmed` remain `NOT_EVALUABLE` without new authorized evidence. This debt does not block CAN SLIM v1 integration/closure.

Canonical closure decision: `docs/decisions/2026-09-15-54-terminal-closure.md`.

## Forward / production boundaries

FWD1 remains LIVE / ACCUMULATING with its existing gate; EXH2 remains separate and prospective. Theory-fidelity findings must not be retrofitted into FWD1/X3/EXH2.

## Active work from here — CAN SLIM v1 closure only

1. **Do not open another theory-expansion workstream.** #54 is closed.
2. Run an end-to-end integration audit across production OHLCV, C/A fundamentals, #33 patterns, #34 candidate semantics, stock-level L/RS evidence, canonical SEC 13F sponsorship `I`, #49/#50 market-state input, #36 entry and #43 lifecycle/exit.
3. Preserve all frozen contracts and explicit debt. Integration may wire components and expose provenance; it must not retune #33/#34/#36/#45/#46 semantics.
4. Verify fail-closed behavior for missing/stale fundamentals, unavailable #51 booleans, non-evaluable 13F identity, missing index volume, and absent next-session execution bars.
5. Verify one canonical end-to-end artifact/schema can explain why a stock is eligible, ineligible, or not evaluable at an `asof_date`, with source/version lineage.
6. After integration verification, publish the CAN SLIM v1 known-limitations/debt register and declare **CAN SLIM v1 — PRODUCTION BASELINE FROZEN**.
7. Then run prospectively. Reopen frozen research only for production bugs or genuinely new governance-compliant evidence.
